KRTAP13-2
gene geneOn this page
Also known as KAP13-2
Summary
KRTAP13-2 (keratin associated protein 13-2, HGNC:18923) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 13-2 (Q52LG2). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to enable structural molecule activity. Predicted to be located in cytosol.
Source: NCBI Gene 337959 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_181621
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18923 |
| Approved symbol | KRTAP13-2 |
| Name | keratin associated protein 13-2 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP13-2 |
| Ensembl gene | ENSG00000182816 |
| Ensembl biotype | protein_coding |
| Entrez | 337959 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000399889
RefSeq mRNA: 1 — MANE Select: NM_181621
NM_181621
CCDS: CCDS13589
Canonical transcript exons
ENST00000399889 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001540640 | 30371390 | 30372271 |
Expression profiles
Bgee: expression breadth broad, 27 present calls, max score 65.16.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0607 / max 42.7273, expressed in 11 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190123 | 0.0607 | 11 |
Top tissues by expression
126 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| rectum | UBERON:0001052 | 65.16 | gold quality |
| transverse colon | UBERON:0001157 | 45.69 | gold quality |
| colon | UBERON:0001155 | 37.77 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| intestine | UBERON:0000160 | 36.34 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| prostate gland | UBERON:0002367 | 34.82 | gold quality |
| skin of abdomen | UBERON:0001416 | 33.71 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 32.48 | gold quality |
| small intestine | UBERON:0002108 | 32.29 | gold quality |
| zone of skin | UBERON:0000014 | 32.19 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| right lung | UBERON:0002167 | 31.51 | silver quality |
| skin of leg | UBERON:0001511 | 31.22 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 29.76 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 29.26 | gold quality |
| liver | UBERON:0002107 | 29.23 | gold quality |
| gall bladder | UBERON:0002110 | 29.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.68 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting KRTAP13-2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-325 | 99.58 | 66.55 | 358 |
| HSA-MIR-622 | 98.99 | 66.48 | 1050 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-4709-5P | 98.51 | 67.25 | 1335 |
| HSA-MIR-6500-3P | 97.42 | 67.20 | 867 |
Literature-anchored findings (GeneRIF, showing 1)
- The KRTAP13-2 promoter is activated by Trichostatin A (TSA) treatment according to promoter reporter assays in HEK 293 cells. (PMID:20494980)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krtap13-1 | ENSMUSG00000056350 |
| rattus_norvegicus | Krtap13-1 | ENSRNOG00000042531 |
Paralogs (8): KRTAP11-1 (ENSG00000182591), KRTAP15-1 (ENSG00000186970), KRTAP13-4 (ENSG00000186971), KRTAP26-1 (ENSG00000197683), KRTAP13-1 (ENSG00000198390), KRTAP27-1 (ENSG00000206107), KRTAP25-1 (ENSG00000232263), KRTAP13-3 (ENSG00000240432)
Protein
Protein identifiers
Keratin-associated protein 13-2 — Q52LG2 (reviewed: Q52LG2)
All UniProt accessions (1): Q52LG2
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the PMG family.
RefSeq proteins (1): NP_853652* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007659 | Keratin_matx | Family |
| IPR007951 | KRTAP_PMG | Family |
Pfam: PF05287
UniProt features (9 total): repeat 5, sequence variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q52LG2-F1 | 46.50 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 44 (showing top):
CATRRAGC_UNKNOWN, FREAC3_01, MARTINEZ_RB1_TARGETS_DN, BRN2_01, TGANTCA_AP1_C, TGACATY_UNKNOWN, YY1_01, YYCATTCAWW_UNKNOWN, chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, YKACATTT_UNKNOWN, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY, GOCC_SUPRAMOLECULAR_COMPLEX
GO Biological Process (0):
GO Molecular Function (2): structural molecule activity (GO:0005198), protein binding (GO:0005515)
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| molecular_function | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
192 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP13-2 | KRTAP19-3 | Q7Z4W3 | 720 |
| KRTAP13-2 | SRRM5 | B3KS81 | 667 |
| KRTAP13-2 | KRTAP19-6 | Q3LI70 | 623 |
| KRTAP13-2 | KRTAP19-2 | Q3LHN2 | 590 |
| KRTAP13-2 | KRTAP19-5 | Q3LI72 | 575 |
| KRTAP13-2 | KRTAP7-1 | Q8IUC3 | 575 |
| KRTAP13-2 | OR1B1 | Q8NGR6 | 573 |
| KRTAP13-2 | KRTAP19-1 | Q8IUB9 | 570 |
| KRTAP13-2 | KRTAP1-1 | Q07627 | 537 |
| KRTAP13-2 | KRTAP9-2 | Q9BYQ4 | 524 |
| KRTAP13-2 | KRTAP8-1 | Q8IUC2 | 513 |
| KRTAP13-2 | LCE2C | Q5TA81 | 445 |
| KRTAP13-2 | LCE2A | Q5TA79 | 435 |
| KRTAP13-2 | LCE2D | Q5TA82 | 434 |
| KRTAP13-2 | KRTAP10-11 | P60412 | 412 |
IntAct
241 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NOTCH2NLC | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GEMIN4 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL38 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | MAGOHB | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP13-2 | TNS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STK16 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-3 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | SLC25A18 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | TSPYL6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GATA3 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | UNC5CL | psi-mi:“MI:0915”(physical association) | 0.560 |
| POU2AF1 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | KRTAP4-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZIC1 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VGLL3 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | SAXO4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPH1 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | KCTD9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-5 | KRTAP13-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | KPRP | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (98): KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid), KRTAP13-2 (Two-hybrid)
ESM2 similar proteins: A8MUX0, O08640, O13152, O93499, O93500, P02438, P02439, P02440, P02448, P02449, P02450, P02451, P04458, P04459, P07521, P08131, P08335, P20307, P20308, P25692, P60329, Q05B44, Q24JX9, Q28580, Q3LI76, Q3LI77, Q3LI83, Q3SY46, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q52LG2, Q6PEX3, Q6R645, Q6R648, Q8IUC0, Q8IUC1, Q8IUC3
Diamond homologs: A1A580, Q3LI77, Q3SY46, Q4W7H0, Q4W7H1, Q52LG2, Q8IUC0, O08640, Q3LI76, Q4W7G7, Q4W7G8, Q4W7G9, Q6R645, Q9QZU5, Q8IUC1
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 76 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 13 | 16.5× | 7e-11 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
403 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30372167:C:CT | donor_gain | 0.8000 |
| 21:30371815:T:TA | donor_gain | 0.7600 |
| 21:30371855:A:AC | donor_gain | 0.7600 |
| 21:30371856:C:CC | donor_gain | 0.7600 |
| 21:30371914:TAGAG:T | donor_gain | 0.7600 |
| 21:30371915:AGAGA:A | donor_gain | 0.7600 |
| 21:30372138:G:C | donor_gain | 0.7400 |
| 21:30372163:G:C | donor_gain | 0.7400 |
| 21:30371837:C:CT | donor_gain | 0.7200 |
| 21:30371662:A:AC | donor_gain | 0.7000 |
| 21:30371663:C:CC | donor_gain | 0.7000 |
| 21:30371689:G:C | donor_gain | 0.6900 |
| 21:30371790:AG:A | donor_gain | 0.6900 |
| 21:30371794:G:T | acceptor_gain | 0.6800 |
| 21:30371910:AGCCT:A | acceptor_gain | 0.6800 |
| 21:30371848:ACAG:A | donor_gain | 0.6700 |
| 21:30371849:CAGC:C | donor_gain | 0.6700 |
| 21:30371880:AG:A | donor_gain | 0.6600 |
| 21:30372000:C:CA | donor_gain | 0.6600 |
| 21:30371791:G:C | donor_gain | 0.6400 |
| 21:30371838:C:CT | donor_gain | 0.6400 |
| 21:30371911:GCCT:G | acceptor_gain | 0.6400 |
| 21:30371462:A:AC | donor_gain | 0.6300 |
| 21:30371463:C:CC | donor_gain | 0.6300 |
| 21:30371549:G:A | donor_gain | 0.6300 |
| 21:30371656:TGAGA:T | donor_gain | 0.6300 |
| 21:30371793:C:CT | acceptor_gain | 0.6300 |
| 21:30372190:T:A | donor_gain | 0.6300 |
| 21:30372051:CC:C | acceptor_gain | 0.6200 |
| 21:30372052:CC:C | acceptor_gain | 0.6200 |
AlphaMissense
1103 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30371908:A:C | F102L | 0.805 |
| 21:30371908:A:T | F102L | 0.805 |
| 21:30371910:A:G | F102L | 0.805 |
| 21:30371803:G:C | F137L | 0.791 |
| 21:30371803:G:T | F137L | 0.791 |
| 21:30371805:A:G | F137L | 0.791 |
| 21:30371776:G:C | F146L | 0.781 |
| 21:30371776:G:T | F146L | 0.781 |
| 21:30371778:A:G | F146L | 0.781 |
| 21:30371704:G:C | F170L | 0.744 |
| 21:30371704:G:T | F170L | 0.744 |
| 21:30371706:A:G | F170L | 0.744 |
| 21:30372184:G:C | F10L | 0.710 |
| 21:30372184:G:T | F10L | 0.710 |
| 21:30372186:A:G | F10L | 0.710 |
dbSNP variants (sampled 300 via entrez): RS1000010431 (21:30372975 C>T), RS1000043056 (21:30373216 A>C), RS1000874994 (21:30373869 C>T), RS1001929949 (21:30371663 CT>C), RS1002354362 (21:30374262 T>G), RS1002718791 (21:30373617 A>C), RS1003118790 (21:30373345 G>A,C), RS1003546482 (21:30371337 A>G), RS1003718944 (21:30372470 C>G,T), RS1004198558 (21:30372434 G>A,C), RS1005938400 (21:30373296 C>A), RS1006245974 (21:30373821 C>A), RS1006627324 (21:30373594 G>A), RS1007392540 (21:30370996 C>A), RS1011131955 (21:30372504 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects expression | 2 |
| perfluorooctanoic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.